Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire1 October 2025
Garmin Ltd. schedules third quarter 2025 earnings call
SCHAFFHAUSEN, Switzerland, Oct. 1, 2025 /PRNewswire/ — Garmin Ltd. (NYSE: GRMN) invites shareholders and investors to listen to its third…
Read More » -
Cision PR Newswire1 October 2025
Way.com and Connects Federal Credit Union Expand Partnership with Way+ Memberships Traveling with GAP Policies, Helping Members Save More
FREMONT, Calif., Oct. 1, 2025 /PRNewswire/ — Way.com, the nation’s leading car services platform, today announced a strategic partnership with…
Read More » -
Cision PR Newswire1 October 2025
German Business Initiative to Invest 735 Billion Euros
BERLIN, Oct. 1, 2025 /PRNewswire/ — The 105-member “Made for Germany” group says it will spend hundreds of billions in the…
Read More » -
Business Wire1 October 2025
Enterra Solutions Earns Numerous Best-in-Class Category Distinctions for the Fourth Consecutive Year In Promotion Optimization Institute’s 2025 Consumer Goods Vendor Panorama
Enterra solidifies its position as a definitive leader in autonomous enterprise optimization, with consistent excellence spanning 2022-2025 PRINCETON, N.J.–(BUSINESS WIRE)–Enterra…
Read More » -
Business Wire1 October 2025
Gregory & Appel Launches Vertical Practices to Enhance Client Experience and Advance Future Growth
INDIANAPOLIS–(BUSINESS WIRE)–#alternativerisk–Gregory & Appel Insurance (G&A), a nationally recognized independent insurance and risk advisory firm, announced a strategic evolution of…
Read More » -
Business Wire1 October 2025
Kwanti Wins WealthManagement.com Industry Award for Portfolio Analytics for Second Consecutive Year
Kwanti also named a finalist in the ThinkAdvisor 2025 Luminaries Awards SAN FRANCISCO–(BUSINESS WIRE)–#Kitces–For the second year in a row,…
Read More » -
Business Wire1 October 2025
ENHERTU® Followed by THP Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Prior to Surgery
Based on results from DESTINY-Breast11, the first phase 3 trial to demonstrate benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in…
Read More » -
Business Wire1 October 2025
Boppy® Just Dropped the ComfyHold and Parents Are About to Be OBSESSED
GOLDEN, Colo.–(BUSINESS WIRE)–#boppy–Parents already know the hip carry. It’s the go-to move when your toddler wants up, but your arms…
Read More » -
Cision PR Newswire1 October 2025
Corteva Announces Plan to Separate into Two Industry-Leading Public Companies
Separation to give shareholders two compelling investment opportunities New Corteva to be a market leader differentiated by its innovative solutions, including biologicals, and focus on operational…
Read More » -
Cision PR Newswire1 October 2025
GOLD ROYALTY REACHES MILESTONE 250TH ASSET AND PROVIDES AN UPDATE ON SELECTED PORTFOLIO ASSETS
VANCOUVER, BC, Oct. 1, 2025 /PRNewswire/ – Gold Royalty Corp. (“Gold Royalty” or the “Company“) (NYSE American: GROY) is pleased to…
Read More »


